Insilico Medicine is based in Boston, Massachusetts. It has raised $416M in total funding. Latest round: Series E.
Insilico Medicine is based in Boston, Massachusetts. Insilico Medicine has raised $416M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series E announced in June 2025. The round record for Insilico Medicine runs through 2025; nothing later has been disclosed. Investors on record include Warburg Pincus, Sequoia Capital, Orbimed, Mirae Asset Financial Group, Deep Knowledge Ventures, JHU A-Level Capital and 2 others. 8 distinct backers are named across the disclosed rounds.
Round data for Insilico Medicine is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Boston and backer lists below.
Company funding database · Investor directory · Founder database · Mega-rounds 2026